{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:27:25Z","timestamp":1770712045647,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.hlc.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T02:00:23Z","timestamp":1713060023000},"page":"675-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension\u2014Real World Data of the Polish Lymphoma Research Group"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-1943","authenticated-orcid":false,"given":"Sebastian","family":"Szmit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"D\u0142ugosz-Danecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4562-6264","authenticated-orcid":false,"given":"Joanna","family":"Drozd-Soko\u0142owska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Joks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Szeremet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"Jurczyszyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Jurczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2024.03.003_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mayocp.2015.09.009","article-title":"Prevalence of preexisting cardiovascular disease in patients with different types of cancer: the unmet need for onco-cardiology","volume":"91","author":"Al-Kindi","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hlc.2024.03.003_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ijcard.2016.06.330","article-title":"The dawn of a new era in onco-cardiology: the Kumamoto Classification","volume":"220","author":"Sueta","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2024.03.003_bib3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2024.03.003_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.critrevonc.2015.11.007","article-title":"Cardiovascular disease following hematopoietic stem cell transplantation: pathogenesis, detection, and the cardioprotective role of aerobic training","volume":"98","author":"Scott","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.hlc.2024.03.003_bib5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jgo.2017.04.001","article-title":"Cardio-oncology in the older adult","volume":"8","author":"Reddy","year":"2017","journal-title":"J\u00a0Geriatr Oncol"},{"key":"10.1016\/j.hlc.2024.03.003_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0360-3016(00)00647-7","article-title":"The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience","volume":"48","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hlc.2024.03.003_bib7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2024.03.003_bib8","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/bcr2901","article-title":"Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study","volume":"13","author":"Patnaik","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.hlc.2024.03.003_bib9","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.ijcard.2013.08.033","article-title":"Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study","volume":"168","author":"Jurczak","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2024.03.003_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2019.01.082","article-title":"Arterial hypertension in cancer: the elephant in the room","volume":"281","author":"Tini","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2024.03.003_bib11","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1200\/JCO.2007.14.1242","article-title":"Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma","volume":"26","author":"Hershman","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hlc.2024.03.003_bib12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jash.2014.08.009","article-title":"Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma","volume":"8","author":"Szmit","year":"2014","journal-title":"J\u00a0Am Soc Hypertens"},{"issue":"1 Suppl","key":"10.1016\/j.hlc.2024.03.003_bib13","first-page":"26","article-title":"Treatment of aggressive non-Hodgkin's lymphoma: a North American perspective","volume":"19","author":"Sehn","year":"2005","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.hlc.2024.03.003_bib14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/cam4.2008","article-title":"The average relative dose intensity of R-CHOP is an independent factor determining favorable overall survival in diffuse large B-cell lymphoma patients","volume":"8","author":"D\u0142ugosz-Danecka","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.hlc.2024.03.003_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bjh.12765","article-title":"Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study","volume":"165","author":"Wieringa","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hlc.2024.03.003_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2017.02.073","article-title":"Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders","volume":"235","author":"Szmit","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2024.03.003_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000492942","article-title":"Primary cardioprotection reduces mortality in lymphoma patients with increased risk of anthracycline cardiotoxicity, treated by R-CHOP regimen","volume":"63","author":"D\u0142ugosz-Danecka","year":"2018","journal-title":"Chemotherapy"},{"key":"10.1016\/j.hlc.2024.03.003_bib18","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.03.003_bib19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hlc.2024.03.003_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hon.2607","article-title":"Cardiovascular mortality among patients with non-Hodgkin lymphoma: differences according to lymphoma subtype","volume":"37","author":"Abuamsha","year":"2019","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.hlc.2024.03.003_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hlc.2024.03.003_bib22","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-08-3392","article-title":"Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma","volume":"107","author":"Moser","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hlc.2024.03.003_bib23","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1200\/JCO.2017.72.4211","article-title":"Preexisting cardiovascular risk and subsequent heart failure among non-Hodgkin lymphoma survivors","volume":"35","author":"Salz","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hlc.2024.03.003_bib24","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/S2352-3026(20)30031-4","article-title":"Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis","volume":"7","author":"Linschoten","year":"2020","journal-title":"Lancet Haematol"},{"issue":"5 Suppl","key":"10.1016\/j.hlc.2024.03.003_bib25","doi-asserted-by":"crossref","first-page":"v116","DOI":"10.1093\/annonc\/mdv304","article-title":"Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Tilly","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hlc.2024.03.003_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjh.15603","article-title":"Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines","volume":"183","author":"Baech","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hlc.2024.03.003_bib27","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/cncr.31981","article-title":"A\u00a0population-based multistate model for diffuse large B-cell lymphoma-specific mortality in older patients","volume":"125","author":"\u00c7a\u011flayan","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.hlc.2024.03.003_bib28","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.03.003_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.blre.2019.03.003","article-title":"Hypertension in hematologic malignancies and hematopoietic cell transplantation: an emerging issue with the introduction of novel treatments","volume":"35","author":"Gavriilaki","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.hlc.2024.03.003_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.critrevonc.2014.08.004","article-title":"Hypertension induced by chemotherapeutic and immunosuppresive agents: a new challenge","volume":"93","author":"Abi Aad","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.hlc.2024.03.003_bib31","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbmt.2014.02.012","article-title":"Late cardiovascular complications after hematopoietic cell transplantation","volume":"20","author":"Chow","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.hlc.2024.03.003_bib32","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/S2352-3026(20)30066-1","article-title":"Cardio-oncology for better lymphoma therapy outcomes","volume":"7","author":"Jurczak","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.hlc.2024.03.003_bib33","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurheartj\/ehy453","article-title":"Cardio-Oncology Services: rationale, organization, and implementation","volume":"40","author":"Lancellotti","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.03.003_bib34","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2217\/fon-2019-0019","article-title":"Treatment of aggressive non-Hodgkin's lymphoma in frail patients: cardiac comorbidities and advanced age","volume":"15","author":"Lugtenburg","year":"2019","journal-title":"Future Oncol"},{"key":"10.1016\/j.hlc.2024.03.003_bib35","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1038\/s41598-020-60565-7","article-title":"Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP - the PLRG report","volume":"10","author":"Drozd-Sokolowska","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.hlc.2024.03.003_bib36","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2024.03.003_bib37","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.03.003_bib38","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.hlc.2024.03.003_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1283831","article-title":"Characteristics of patients with newly diagnosed hematological malignancies referred for echocardiography","volume":"14","author":"K\u0119pski","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.hlc.2024.03.003_bib40","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hlc.2024.03.003_bib41","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950624001574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950624001574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T06:20:40Z","timestamp":1717654840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950624001574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1443950624001574"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2024.03.003","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension\u2014Real World Data of the Polish Lymphoma Research Group","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}